Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications.

Ong KW, Teo M, Lee V, Ong D, Lee A, Tan CS, Vathsala A, Toh HC.

Clin Cancer Res. 2009 Sep 1;15(17):5350-8. doi: 10.1158/1078-0432.CCR-08-2979. Epub 2009 Aug 25.

2.
4.

Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.

Lin F, Zhang PL, Yang XJ, Prichard JW, Lun M, Brown RE.

Ann Clin Lab Sci. 2006 Summer;36(3):283-93.

PMID:
16951269
5.

Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.

Fendri A, Masmoudi A, Khabir A, Sellami-Boudawara T, Daoud J, Frikha M, Ghorbel A, Gargouri A, Mokdad-Gargouri R.

Cancer Biol Ther. 2009 Mar;8(5):444-51. Epub 2009 Mar 21.

PMID:
19221469
6.
7.

The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.

Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F, Papa V, Libra M, Martinelli G, Cocco L, Martelli AM.

Cancer Res. 2007 May 1;67(9):4287-94.

8.

Atypical Epstein-Barr virus (EBV) latent protein expression in EBV-associated smooth muscle tumours occurring in paediatric transplant recipients.

Rougemont AL, Alfieri C, Fabre M, Gorska-Flipot I, Papp E, Champagne J, Phan V, Fournet JC, Sartelet H.

Histopathology. 2008 Sep;53(3):363-7. doi: 10.1111/j.1365-2559.2008.03086.x. No abstract available.

PMID:
18631193
9.

Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas.

Dobashi Y, Suzuki S, Matsubara H, Kimura M, Endo S, Ooi A.

Cancer. 2009 Jan 1;115(1):107-18. doi: 10.1002/cncr.23996.

10.

Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma.

Di Paolo S, Teutonico A, Ranieri E, Gesualdo L, Schena PF.

Am J Kidney Dis. 2007 Mar;49(3):462-70.

PMID:
17336708
11.
12.

Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma.

Woodard J, Sassano A, Hay N, Platanias LC.

Clin Cancer Res. 2008 Jul 15;14(14):4640-9. doi: 10.1158/1078-0432.CCR-07-5232.

13.

Analysis of human papillomavirus and Epstein-Barr virus infection and aberrant death-associated protein kinase methylation in high-grade squamous intraepithelial lesions.

Lattario F, Furtado YL, Fonseca R, Silveira FA, do Val IC, Almeida G, Carvalho MG.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):785-9. Epub 2007 Sep 14.

PMID:
17868341
14.

Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.

Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.

Clin Cancer Res. 2008 May 1;14(9):2664-72. doi: 10.1158/1078-0432.CCR-07-1232.

15.

Synchronous hepatic, mesenteric and pulmonary Epstein-Barr virus-associated smooth muscle tumors in a renal transplant recipient.

Al Hussain T, Haleem A, Alsaad KO.

Clin Transplant. 2010 Sep-Oct;24(5):579-84. doi: 10.1111/j.1399-0012.2009.01206.x.

PMID:
20156224
16.

Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.

Feng W, Brown RE, Trung CD, Li W, Wang L, Khoury T, Alrawi S, Yao J, Xia K, Tan D.

Ann Clin Lab Sci. 2008 Summer;38(3):195-209.

PMID:
18715846
17.

Multicentric hepatic EBV-associated smooth muscle tumors in an AIDS patient: a case report, investigation of mTOR activation and review of the literature.

Shen Q, Feng W, Long MS, Duan X, Jaijakul S, Arias CA, Brown RE, Zhao B.

Int J Clin Exp Pathol. 2011 Apr;4(4):421-9. Epub 2011 Apr 23. Review.

18.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
19.

Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer.

Nozawa H, Watanabe T, Nagawa H.

Cancer Lett. 2007 Jun 18;251(1):105-13. Epub 2006 Dec 18.

PMID:
17175097
20.

Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy.

Faried LS, Faried A, Kanuma T, Aoki H, Sano T, Nakazato T, Tamura T, Kuwano H, Minegishi T.

Mol Carcinog. 2008 Jun;47(6):446-57.

PMID:
18058806

Supplemental Content

Support Center